[LIPO] QoQ Quarter Result on 30-Sep-2023 [#Q3]

Stock
[LIPO] Lipella Pharmaceuticals Inc.
Announcement Date
14-Nov-2023
Financial Year
2023
Quarter
30-Sep-2023 [#Q3]
Profit Trend
QoQ- 13.97%
YoY- -85.69%
Quarter Report
LIPO's Result
LIPO's Financial Summary
View:
Show?
Quarter Result
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
Revenue 136,431 146 121 104,051 106,676 118 151 9284.80%
PBT -938 -1,192 -689 -1,324 -1,539 -1,068 -364 88.06%
Tax 0 -0 -58,388 33,124 36,477 -11,213 -1 -
NP -938,146 -1,192 -689 -1,324 -1,539 10,145 -363 18822.94%
Tax Rate - - - - - - - -
Total Cost 1,074,577 1,338 810 105,375 108,215 -10,027 514 16326.29%
Ratio Analysis
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
NP Margin -687.63 -816.98 -570.07 -1.27 -1.44 8,594.11 -240.25 101.71%
Per Share
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
EPS -0.12 -0.16 -0.11 -0.23 -0.27 1.77 -0.06 58.80%
EPS Diluted -0.12 -0.16 -0.11 -0.23 -0.27 1.77 -0.06 58.80%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.